WEC
Winslow Evans & Crocker’s Elevance Health ELV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | $608K | Buy |
1,896
+64
| +3% | +$20.5K | 0.12% | 182 |
|
2020
Q3 | $492K | Buy |
1,832
+231
| +14% | +$62K | 0.12% | 164 |
|
2020
Q2 | $421K | Buy |
1,601
+617
| +63% | +$162K | 0.11% | 175 |
|
2020
Q1 | $226K | Buy |
984
+160
| +19% | +$36.7K | 0.07% | 223 |
|
2019
Q4 | $250K | Buy |
824
+56
| +7% | +$17K | 0.06% | 253 |
|
2019
Q3 | $186K | Sell |
768
-260
| -25% | -$63K | 0.05% | 289 |
|
2019
Q2 | $292K | Sell |
1,028
-954
| -48% | -$271K | 0.08% | 241 |
|
2019
Q1 | $570K | Sell |
1,982
-12
| -0.6% | -$3.45K | 0.16% | 143 |
|
2018
Q4 | $526K | Buy |
1,994
+594
| +42% | +$157K | 0.18% | 129 |
|
2018
Q3 | $384K | Buy |
1,400
+1,124
| +407% | +$308K | 0.12% | 182 |
|
2018
Q2 | $66K | Hold |
276
| – | – | 0.02% | 444 |
|
2018
Q1 | $60.2K | Sell |
276
-14
| -5% | -$3.05K | 0.02% | 448 |
|
2017
Q4 | $65K | Sell |
290
-70
| -19% | -$15.7K | 0.02% | 440 |
|
2017
Q3 | $68.2K | Buy |
360
+1
| +0.3% | +$189 | 0.02% | 418 |
|
2017
Q2 | $67.5K | Sell |
359
-1
| -0.3% | -$188 | 0.02% | 497 |
|
2017
Q1 | $59.4K | Hold |
360
| – | – | 0.02% | 503 |
|
2016
Q4 | $51.6K | Hold |
360
| – | – | 0.02% | 528 |
|
2016
Q3 | $45K | Hold |
360
| – | – | 0.01% | 563 |
|
2016
Q2 | $47.2K | Buy |
360
+251
| +230% | +$32.9K | 0.01% | 526 |
|
2016
Q1 | $15.2K | Sell |
109
-103
| -49% | -$14.3K | ﹤0.01% | 773 |
|
2015
Q4 | $29.2K | Buy |
212
+2
| +1% | +$276 | 0.01% | 654 |
|
2015
Q3 | $29.3K | Sell |
210
-4,476
| -96% | -$624K | 0.01% | 625 |
|
2015
Q2 | $769K | Sell |
4,686
-38
| -0.8% | -$6.24K | 0.22% | 110 |
|
2015
Q1 | $729K | Buy |
4,724
+4,476
| +1,805% | +$691K | 0.21% | 109 |
|
2014
Q4 | $31K | Buy |
248
+38
| +18% | +$4.76K | 0.01% | 636 |
|
2014
Q3 | $25K | Buy |
210
+1
| +0.5% | +$119 | 0.01% | 689 |
|
2014
Q2 | $22.5K | Hold |
209
| – | – | 0.01% | 649 |
|
2014
Q1 | $20.8K | Hold |
209
| – | – | 0.01% | 662 |
|
2013
Q4 | $19K | Buy |
+209
| New | +$19K | 0.01% | 712 |
|